Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
5.70
-1.90 (-25.00%)
Feb 27, 2026, 4:00 PM EST - Market closed

Puma Biotechnology Revenue

In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%. Puma Biotechnology had revenue of $75.45M in the quarter ending December 31, 2025, with 27.72% growth.

Revenue (ttm)
$228.37M
Revenue Growth
-0.91%
P/S Ratio
1.26
Revenue / Employee
$1,327,738
Employees
172
Market Cap
287.23M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025228.37M-2.10M-0.91%
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

PBYI News

More News